Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel palladium-catalyzed reductive aminocarbonylation enables high-purity chromane amide intermediates with simplified supply chain and reduced manufacturing costs.
Patent CN115260080B enables high-purity indole-3-carboxamide production through efficient palladium-catalyzed carbonylation, reducing lead time and manufacturing costs for pharmaceutical intermediates.
Patent CN114539198B enables cost-effective fine chemical production through nitroarene-based aminocarbonylation with simplified purification and broad functional group tolerance.
Patent CN115260080B enables high-purity indole-3-carboxamide synthesis through palladium-catalyzed carbonylation, eliminating transition metal residues and reducing manufacturing costs via simplified purification.
Patent CN117164534A enables high-purity benzofuran intermediates through simplified catalysis, reducing manufacturing costs and enhancing supply chain reliability for pharmaceutical producers.
Novel nickel-catalyzed method eliminates CO gas using molybdenum carbonyl for high-purity API intermediates with scalable production and reduced lead time.
Novel palladium-catalyzed method using nitroarenes enables cost-effective production of high-purity (iso)chroman amides with improved supply chain reliability.
Novel copper-catalyzed one-pot synthesis achieves 98.1% purity with environmental benefits, enhancing supply chain reliability for pharmaceutical intermediates.
Novel palladium-catalyzed method using nitroarenes as nitrogen source enables high-purity chromane amide production with simplified supply chain and reduced manufacturing costs.
Patent CN115260080B enables efficient indole-3-carboxamide synthesis with high purity. This method reduces manufacturing costs and ensures reliable supply for pharmaceutical intermediates.
Patent CN114539198B enables efficient synthesis of high-purity amide intermediates with streamlined process reducing lead time and manufacturing costs.
Patent CN115260080B enables high-purity indole-3-carboxamide production through palladium-catalyzed carbonylation, reducing lead times and ensuring scalable supply for pharmaceutical applications.
Patent CN110615811A enables high-purity chiral ligand synthesis via crystallization method eliminating column chromatography thus reducing manufacturing costs and improving supply chain reliability.
Patent CN119161318A enables mild synthesis of high-purity benzopyran derivatives with broad functional group tolerance, reducing lead time and costs for pharmaceutical intermediates.
Patent CN114539198B enables high-purity API intermediates through innovative reductive aminocarbonylation, reducing supply chain complexity and manufacturing costs.
Patent CN113861086B enables high-yield synthesis of complex intermediates with simplified process and reduced environmental impact, ensuring reliable pharmaceutical supply chains.
Patent CN114751883B enables high-purity benzofuran API intermediates through scalable carbonylation, reducing manufacturing costs and lead times for pharmaceutical supply chains.
Patent CN114751883B enables high-purity pharmaceutical intermediates through streamlined catalysis, reducing lead time and manufacturing costs.
Patent CN114539198B enables high-purity API intermediates through streamlined catalysis, reducing lead time and manufacturing costs for pharmaceutical supply chains.
Patent CN117164544A enables efficient pyrone synthesis using nitroarenes and molybdenum carbonyl, reducing costs and lead times for high-purity API intermediates.